Bots, editor, reviewer, Administrators
13,941
edits
(Replaced content with "{ "trial_acronyms" : {} }") |
No edit summary |
||
Line 1: | Line 1: | ||
{ | { | ||
"trial_acronyms" : {} | "trial_acronyms" : { | ||
"A-HeFT" : "African-American Heart Failure Trial", | |||
"SPARCL" : "Stroke Prevention by Aggressive Reduction in Cholesterol Levels", | |||
"RE-COVER" : "Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism", | |||
"RALES" : "Randomized Aldactone Evaluation Study", | |||
"ASPIRE" : "Aspirin to Prevent Recurrent Venous Thromboembolism", | |||
"TACTICS-TIMI 18" : "Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban", | |||
"EASE" : "Early Surgery versus Conventional Treatment in Infective Endocarditis", | |||
"ISAR-REACT 5" : "Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 5 Trial", | |||
"TRISS" : "Transfusion Requirements in Septic Shock", | |||
"TRAPS" : "Trial on Rivaroxaban in AntiPhospholipid Syndrome", | |||
"HEMO" : "Hemodialysis", | |||
"BEST" : "The Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation", | |||
"ALBIOS" : "Albumin Italian Outcome Sepsis", | |||
"JUPITER" : "Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin", | |||
"ESCAPE" : "Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness", | |||
"PIONEER-HF" : "comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode", | |||
"ICAP" : "Evaluation of additive benefit of colchicine to conventional therapy in acute pericarditis", | |||
"ANNEXA" : "Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of FXA Inhibitors", | |||
"STAMPEDE" : "Surgical Treatment and Medications Potentially Eradicate Diabetes Efficiently", | |||
"EUROPA" : "European Trial on Reduction of Cardiac Events with Perindopril in Patients with Stable Coronary Artery Disease", | |||
"DPP" : "Diabetes Prevention Program", | |||
"WISDOM" : "Withdrawal of Inhaled Steroids during Optimized Bronchodilator Management", | |||
"PCPT" : "Prostate Cancer Prevention Trial", | |||
"HEAT" : "Permissive Hyperthermia through Avoidance of Acetaminophen in Known or Suspected Infection in the Intensive Care Unit", | |||
"COPERNICUS" : "Carvedilol Prospective Randomized Cumulative Survival", | |||
"SCD-HeFT" : "Sudden Cardiac Death in Heart Failure Trial", | |||
"Look AHEAD" : "Look Action for HEAlth in Diabetes", | |||
"HEARTMATE II" : "Advanced heart failure treated with continuous-flow left ventricular assist device", | |||
"CABANA" : "Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation", | |||
"RE-LY" : "Randomized Evaluation of Long-Term Anticoagulation Therapy", | |||
"TREAT" : "Trial to Reduce Cardiovascular Events With Aranesp Therapy", | |||
"SPYRAL HTN-ON MED" : "Global Clinical Study of Renal Denervation With the Symplicity Spyral Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy", | |||
"CORAL" : "Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis", | |||
"SYNTAX" : "Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery", | |||
"PIOPED II" : "Prospective Investigation of Pulmonary Embolism Diagnosis II", | |||
"EUCLID" : "Examining use of ticagrelor in peripheral artery disease", | |||
"COAPT" : "Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation", | |||
"Oscillate" : "Oscillation for Acute Respiratory Distress Syndrome Treated Early", | |||
"ATLAS" : "Adjuvant Tamoxifen: Longer Against Shorter", | |||
"IDEAL-ICU" : "Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit", | |||
"DIVA" : "Rationale and design of the drug-eluting stents vs bare-metal stents in saphenous vein graft angioplasty", | |||
"TIMACS" : "The Timing of Intervention in Acute Coronary Syndromes", | |||
"NINDS" : "National Institute of Neurological Disorders and Stroke rt-PA Stroke Study", | |||
"PARADIGM-HF" : "Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure", | |||
"TRITON-TIMI 38" : "Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel–Thrombolysis in Myocardial Infarction 38", | |||
"HYVET" : "Hypertension in the Very Elderly Trial", | |||
"CREDENCE" : "Canagliflozin and Renal Events in Diabetes and Nephropathy Clinical Evaluation", | |||
"PRORATA" : "Procalcitonin to Reduce Antibiotic Treatments in Acutely ill patients", | |||
"PROFESS" : "Prevention Regimen for Effectively Avoiding Second Strokes", | |||
"CANTOS" : "Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)", | |||
"TALC" : "Tiotropium Bromide as an Alternative to Increased Inhaled Glucocorticoid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid", | |||
"AASK" : "African American Study of Kidney Disease and Hypertension", | |||
"NORSTENT" : "Drug-Eluting or Bare-Metal Stents for Percutaneous Coronary Intervention in Stable or Unstable Coronary Artery Disease", | |||
"CHOIR" : "Correction of Hemoglobin and Outcomes in Renal Insufficiency", | |||
"BASALT" : "Best Adjustment Strategy for Asthma in the Long Term", | |||
"SMART" : "Isotonic Solutions and Major Adverse Renal Events Trial", | |||
"AMAZES" : "Azithromycin on Asthma Exacerbations and Quality of Life in Adults With Persistent Uncontrolled Asthma", | |||
"POISE-2 ASA" : "Perioperative ischemic evaluation 2 aspirin arm", | |||
"POINT" : "Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial", | |||
"CvLPRIT" : "Complete Versus Lesion-Only Primary PCI Trial", | |||
"CATIE" : "Clinical Antipsychotic Trials of Intervention Effectiveness", | |||
"ACCORD BP" : "ACCORD Study Group", | |||
"FAME 2" : "FFR vs. Angiographyfor Multivessel Evaluation 2", | |||
"ARDSNet" : "Acute Respiratory Distress Syndrome Network", | |||
"SPICE III" : "Sedation Practice in Intensive Care Evaluation", | |||
"OVIVA" : "Oral versus Intravenous Antibiotics for Bone and Joint Infection", | |||
"DAWN" : "DWI or CTP Assessment with Clinical Mismatch in the Triage of Wake-Up and Late Presenting Strokes Undergoing Neurointervention with Trevo", | |||
"ProCESS" : "Protocolized Care for Early Septic Shock", | |||
"ADVANCE" : "Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation", | |||
"ARISE" : "Australasian Resuscitation in Sepsis Evaluation", | |||
"CREST" : "Carotid Revascularization Endarterectomy vs. Stenting Trial", | |||
"SPACE" : "Strategies for Prescribing Analgesics Comparative Effectiveness", | |||
"DOSE" : "Diuretic Optimization Strategies Evaluation", | |||
"PROSEVA" : "Proning Severe ARDS Patients", | |||
"WASID" : "Warfarin-Aspirin Symptomatic Intracranial Disease", | |||
"SAFE" : "Saline versus Albumin Fluid Evaluation", | |||
"MADIT-CRT" : "Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy", | |||
"POET" : "Partial Oral Treatment of Endocarditis", | |||
"SPS3-BP" : "Secondary Prevention of Small Subcortical Strokes-Blood Pressure", | |||
"CHANCE" : "Clopidogrel in High-risk patients with Acute Nondisabling Cerebrovascular Events", | |||
"CORTICUS" : "Corticosteroid Therapy of Septic Shock", | |||
"UKPDS" : "United Kingdom Prospective Diabetes Study", | |||
"AIRTRIP" : "AnakInRa for Treatment of Recurrent Idiopathic Pericarditis", | |||
"AFFIRM" : "Atrial Fibrillation Follow-up Investigation of Rhythm Management", | |||
"EINSTEIN CHOICE" : "Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic Venous Thromboembolism", | |||
"COURAGE" : "Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation", | |||
"AVOID" : "Comparing Oxygen with normal air in patients with ST-Segment Elevation Myocardial Infarction who are not hypoxic.", | |||
"SAVE" : "Survival and Ventricular Enlargement Trial", | |||
"PIONEER AF-PCI" : "Open-Label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects with AF who Undergo Percutaneous Coronary Intervention", | |||
"BLOCK-HF" : "Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block", | |||
"NASCET" : "North American Symptomatic Carotid Endarterectomy Trial", | |||
"CAPRICORN" : "Carvedilol Post-Infarct Survival Control in LV Dysfunction", | |||
"ESSENCE" : "Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-Wave Coronary Events Study Group", | |||
"CRASH-2" : "Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2", | |||
"3C" : "Cough Complication Cohort", | |||
"CHOICE" : "CHOICE is not an abbreviation per a communication with the research team", | |||
"SELECT-D" : "Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism", | |||
"AMPLIFY" : "Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy", | |||
"PRECISION" : "Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen", | |||
"AIDA" : "Amsterdam Investigator-Initiated Absorb Strategy All-Comers Trial", | |||
"PARTNER 3" : "Placement of Aortic Transcatheter Valves 3", | |||
"V-HeFT" : "Vasodilator Heart Failure Trial", | |||
"EPCAT II" : "Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty II", | |||
"TTM" : "Target Temperature Management 33°C vs. 36°C after Out-of Hospital Cardiac Arrest", | |||
"COGENT" : "Clopidogrel and the Optimization of Gastrointestinal Events Trial", | |||
"COMMIT/CCS-2" : "ClOpidogrel and Metoprolol in Myocardial Infarction Trial / Second Chinese Cardiac Study", | |||
"GUSTO" : "Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries", | |||
"SOCRATES" : "Ticagrelor versus aspirin in stroke/TIA", | |||
"PROWESS-SHOCK" : "Prospective Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis and Septic Shock", | |||
"HOPE" : "Heart Outcomes Prevention Evaluation", | |||
"AVERROES" : "Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment", | |||
"HACA" : "Hypothermia After Cardiac Arrest", | |||
"CHARISMA" : "Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance", | |||
"DAPA-HF" : "Dapagliflozin in Heart Failure", | |||
"RAVE" : "Rituximab in ANCA-Associated Vasculitis", | |||
"ARREST" : "Adjunctive rifampicin for Staphylococcus Aureus Bacteraemia", | |||
"IDNT" : "Irbesartan Diabetic Nephropathy Trial", | |||
"SOAP II" : "Sepsis Occurrence in Acutely Ill Patients II", | |||
"MERIT-HF" : "Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure", | |||
"NSABP B-32" : "National Surgical Adjuvant Breast and Bowel Project Trial B-32", | |||
"CLOSURE I" : "Evaluation of the STARFlex Septal Closure System in Patients with a Stroke and/or Transient Ischemic Attack due to Presumed Paradoxical Embolism through a Patent Foramen Ovale", | |||
"RAFT" : "Resynchronization–Defibrillation for Ambulatory Heart Failure", | |||
"SPAF" : "Stroke Prevention in Atrial Fibrillation", | |||
"TRIUMPH" : "Transfusion Reduction Efficacy and Safety Clinical Investigation, a Randomized, Multicenter, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal Hemoglobinuria", | |||
"VADT" : "Veterans Affairs Diabetes Trial", | |||
"PREPIC 2" : "Prevention du Risque d'Embolie Pulmonaire par Interruption Cave 2", | |||
"MOMENTUM 3" : "Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3", | |||
"ERSPC" : "European Randomized Study of Screening for Prostate Cancer", | |||
"PREPIC" : "Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group", | |||
"TRICC" : "Transfusion Requirements in Critical Care", | |||
"REDUCE-IT" : "Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial", | |||
"REDUCE" : "Reduction in the Use of Corticosteroids in Exacerbated COPD", | |||
"HERA" : "Herceptin Adjuvant Trial", | |||
"BARI 2D" : "Bypass Angioplasty Revascularization Investigation 2 Diabetes", | |||
"DANISH" : "Danish Study to Assess the Efficacy of ICDs in Patients with Non-ischemic Systolic Heart Failure on Mortality", | |||
"DANAMI-3 PRIMULTI" : "Third Danish Study of Optimal Acute Treatment of Patients with STEMI: Primary PCI in Multivessel Disease", | |||
"PANTER" : "Minimally Invasive Step Up Approach versus Maximal Necrosectomy in Patients with Acute Necrotising Pancreatitis", | |||
"RED-HF" : "Reduction of Events by Darbepoetin Alfa in Heart Failure", | |||
"ATTR-ACT" : "The Transthyretin Amyloidosis Cardiomyopathy Clinical Trial", | |||
"B-CONVINCED" : "Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode", | |||
"EDIC" : "Epidemiology of Diabetes Interventions and Complications", | |||
"RENAAL" : "Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan", | |||
"FAIR-HF" : "IV Iron for Symptoms in Patients with HFrEF and Iron Deficiency", | |||
"Blood-Pressure Reduction in Black Barbershops" : "Blood-Pressure Reduction in Black Barbershops", | |||
"StiL" : "Study Group Indolent Lymphomas", | |||
"RESCUEicp" : "Randomised Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of Intracranial Pressure", | |||
"ALLHAT" : "Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial", | |||
"CLOT" : "Comparison of Low Molecular Weight Heparin Versus Oral Anticoagulant Therapy for Long Term Anticoagulation in Cancer Patients With Venous Thromboembolism", | |||
"TRICS III" : "Transfusion Requirements in Cardiac Surgery", | |||
"ISIS-2" : "Second International Study of Infarct Survival", | |||
"BeSt" : "Behandel-Strategeieën (\"treatment strategies\" in Dutch)", | |||
"PROVE IT-TIMI 22" : "Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22", | |||
"EVEREST" : "Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan", | |||
"CULPRIT-SHOCK" : "Culprit Lesion Only PCI versus Multivessel PCI in Cardiogenic Shock", | |||
"NETT" : "National Emphysema Treatment Trial", | |||
"APEX" : "Acutely Medically Ill VTE Prevention with Extended Duration Betrixaban", | |||
"MARINER" : "Medically Ill Patient Assessment of Rivaroxaban versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism Risk", | |||
"TOPCAT" : "Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist", | |||
"DAPT" : "Dual Antiplatelet Therapy", | |||
"SPS3-Clopidogrel+ASA" : "Secondary Prevention of Small Subcortical Strokes clopidogrel+ASA", | |||
"CARRESS-HF" : "Cardiorenal Rescue Study in Acute Decompensated Heart Failure", | |||
"DASH" : "Dietary Approaches to Stop Hypertension", | |||
"MUSTT" : "Multicenter Unsustained Tachycardia Trial", | |||
"WOSCOPS" : "West of Scotland Coronary Prevention Study", | |||
"OASIS-5" : "Fifth Organization to Assess Strategies in Acute Ischemic Syndromes", | |||
"V-HeFT II" : "Vasodilator Heart Failure Trial II", | |||
"FACTT" : "Fluids and Catheters Treatment Trial", | |||
"CIRT" : "Cardiovascular Inflammation Reduction Trial", | |||
"SOLVD" : "Studies of Left Ventricular Dysfunction", | |||
"MSH" : "Multicenter Study of Hydroxyurea in Sickle-Cell Anemia", | |||
"iPrEx" : "Iniciativa Profilaxis Pre Exposicion (\"Preexposure Prophylaxis Initiative\")", | |||
"ORBIT-AF" : "Outcomes Registry for Better Informed Treatment of Atrial Fibrillation", | |||
"EXTRA" : "A Study of Omalizumab/Xolair in Subjects With Moderate to Severe Persistent Asthma", | |||
"EMBRACE" : "30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation after a Cerebral Ischemic Event", | |||
"SPRINT" : "Systolic Blood Pressure Intervention Trial", | |||
"iFR-SWEDEHEART" : "Instantaneous Wave-free Ratio versus Fractional Flow Reserve in Patients with Stable Angina Pectoris or Acute Coronary Syndrome", | |||
"RESPECT" : "Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment", | |||
"CAST I" : "Cardiac Arrhythmia Suppression Trial", | |||
"LESS" : "Lumbar Epidural Steroid Injections for Spinal Stenosis", | |||
"RECOVERY" : "Randomized Evaluation of Covid-19 Therapy", | |||
"FEAST" : "Fluid Expansion as Supportive Therapy", | |||
"TNT" : "Treating to New Targets", | |||
"ACTT-1" : "Adaptive Covid-19 Treatment Trial", | |||
"DAVID" : "Dual-chamber pacing or ventricular backup pacing in ICD patients", | |||
"CAPRIE" : "Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events", | |||
"IRONOUT-HF" : "Iron Repletion Effects on Oxygen Uptake in Heart Failure", | |||
"ACOSOG Z0011" : "The American College of Surgeons Oncology Group (ACOSOG) Z0011", | |||
"MADIT-II" : "Multicenter Automatic Defibrillator Implantation Trial II", | |||
"AATAC" : "Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device", | |||
"TIPPS" : "Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia", | |||
"DCCT" : "Diabetes Control and Complications Trial", | |||
"4S" : "Scandinavian Simvastatin Survival Study", | |||
"ONTARGET" : "Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial", | |||
"ACCORD Lipid" : "Action to Control Cardiovascular Risk in Diabetes-Lipid", | |||
"PEITHO" : "Pulmonary Embolism Thrombolysis trial", | |||
"EPHESUS" : "Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study", | |||
"LEADER" : "Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results", | |||
"MAGELLAN" : "Multicenter, Randomized, Parallel Group Efficacy and Safety Study for the Prevention of Venous Thromboembolism in Hospitalized Acutely Ill Medical Patients Comparing Rivaroxaban with Enoxaparin", | |||
"PROTECT AF" : "WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation", | |||
"CAP-START" : "Community-Acquired Pneumonia—Study on the Initial Treatment with Antibiotics of Lower Respiratory Tract Infections", | |||
"STAR-D" : "Sequenced Treatment Alternatives to Relieve Depression", | |||
"EXCEL" : "XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL)", | |||
"FREEDOM" : "Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease", | |||
"STOP-IT" : "Study to Optimize Peritoneal Infection Therapy", | |||
"AVERT" : "Apixaban for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients", | |||
"CASSINI" : "Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer", | |||
"EVOLVE" : "Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis", | |||
"AUGUSTUS" : "An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention", | |||
"FAME" : "Fractional Flow Reserve versus Angiography for Multivessel Evaluation", | |||
"CHARM-Preserved" : "Candesartan in Heart failure Assessment of Reduction in Mortality and Morbidity-Preserved", | |||
"ACURASYS" : "ARDS et Curarisation Systematique", | |||
"ADJUST-PE" : "Age aDJUSTed D-Dimer to rule out PE", | |||
"DETO2X-AMI" : "Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction", | |||
"MATCH" : "Management of Atherothrombosis with Clopidogrel in High-risk patients", | |||
"PREDIMED" : "Prevención con Dieta Mediterránea", | |||
"PLATO" : "Platelet Inhibition and Patient Outcomes", | |||
"ORIGIN n-3 Fatty Acids" : "Investigators in the outcome Reduction with an Initial Glargine Intervention", | |||
"ART" : "Arterial Revascularization Trial", | |||
"IRIS" : "International Randomized Study of Interferon and STI571", | |||
"ASCEND" : "Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis", | |||
"VANISH" : "Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs", | |||
"ESPRIT" : "European/Australasian Stroke Prevention in Reversible Ischaemia Trial", | |||
"ATHOS-3" : "Angiotensin II for the Treatment of High-Output Shock", | |||
"ARISTOTLE" : "Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation", | |||
"PROWESS" : "Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis", | |||
"ENGAGE AF-TIMI 48" : "Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation - Thrombolysis in Myocardial Infarction 48", | |||
"CAMERA" : "Computer Assisted Management in Early Rheumatoid Arthritis", | |||
"COMPASS" : "Cardiovascular Outcomes for People Using Anticoagulation Stratgies", | |||
"STAR" : "Study of Tamoxifen and Raloxifene (NSABP P-2)", | |||
"MPACT" : "Metastatic Pancreatic Adenocarcinoma Clinical Trial", | |||
"DONATE HCV" : "Donors of Hepatitis C NAT Positive Thoracic Allografts for Transplantation Evaluation in Non-HCV Recipients", | |||
"PARTNER A" : "Placement of Aortic Transcatheter Valves, Cohort A", | |||
"SHIFT" : "Systolic Heart failure treatment with the If inhibitor ivabradine Trial", | |||
"SONIC" : "Study of Biologic and Immunomodulator Naive Patients in Crohn's Disease", | |||
"MIRACL" : "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering", | |||
"NCDS" : "The National Cooperative Dialysis Study", | |||
"PARAGON-HF" : "Prospective Comparison of ARNI Global Outcomes in HF with Preserved Ejection Fraction", | |||
"ACTIVE W" : "Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events", | |||
"SEDCOM" : "Safety and Efficacy of Dexmedetomidine Compared with Midazolam", | |||
"TRED-HF" : "Treatment for heart failure in patients with recovered dilated cardiomyopathy", | |||
"GISSI-3" : "Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico", | |||
"PRAMI" : "Preventative Angioplasty in Acute Myocardial Infarction", | |||
"RACE II" : "Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control II", | |||
"AURORA" : "A Study to Evaluate the Use of Rosuvastatin in Subjects on Regular Hemodialysis: An Assessment of Survival and Cardiovascular Events", | |||
"IABP-SHOCK II" : "Intraaortic Balloon Pump in Cardiogenic Shock II", | |||
"VITAMINS" : "The VitamIn C, HydrocorTisone and ThiAMINe in Patients With Septic Shock Trial", | |||
"PARTNER 2" : "Placement of Aortic Transcatheter Valves, Cohort A", | |||
"VEST" : "Vest Prevention of Early Sudden Death", | |||
"LoDoCo" : "Low-Dose Colchicine", | |||
"CHAMPION PHOENIX" : "Cangrelor versus standard therapy to achieve optimal management of platelet inhibition", | |||
"NA-ACCORD" : "North American AIDS Cohort Collaboration on Research and Design", | |||
"RE-ALIGN" : "Randomized, Phase II Study to Evaluate the Safety and Pharmacokinetics of Oral Dabigatran Etexilate in Patients after Heart Valve Replacement", | |||
"ASPREE" : "Aspirin in Reducing Events in the Elderly", | |||
"CANVAS" : "Canagliflozin Cardiovascular Assessment Study", | |||
"SEPSISPAM" : "Sepsis and Mean Arterial Pressure", | |||
"AKIKI" : "Artificial Kidney Initiation in Kidney Injury", | |||
"ALMS" : "Aspreva Lupus Management Study", | |||
"ECST" : "European Carotid Surgery Trial", | |||
"DEFINITE" : "Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation", | |||
"WHI E+P" : "Women's Health Initiative Estrogen and Progestin Trial", | |||
"RE-DUAL PCI" : "Randomized evaluation of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin in patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention", | |||
"HPS2-THRIVE" : "Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events", | |||
"COMET" : "Carvedilol Or Metoprolol European Trial", | |||
"NSABP P-1" : "National Surgical Adjuvant Breast and Bowel Project, Prevention-1", | |||
"VASST" : "Vasopressin and Septic Shock Trial", | |||
"IALT" : "International Adjuvant Lung Cancer Trial", | |||
"EMILIA" : "Emtansine vs. Capecitabine+Lapatinib in Patients with HER2-Positive Locally Advanced or Metastatic Breast Cancer", | |||
"WOEST" : "What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing", | |||
"ATLAS ACS 2-TIMI 51" : "Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 51", | |||
"RELAX" : "Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Heart Failure with Preserved Ejection Fraction", | |||
"ACCORD" : "Action to Control Cardiovascular Risk in Diabetes", | |||
"VA NEPHRON-D" : "Veterans Affairs Nephropathy in Diabetes", | |||
"Val-HeFT" : "Valsartan Heart Failure Trial", | |||
"CRISTAL" : "Colloids Versus Crystalloids for the Resuscitation of the Critically Ill", | |||
"HPS" : "Heart Protection Study Statin Arm", | |||
"MIND-USA" : "Modifying the Impact of ICU-Associated Neurological Dysfunction–USA", | |||
"CATT" : "Comparison of Age-Related Macular Degeneration Treatment Trails", | |||
"PRODIGE 4 ACCORD 11" : "PRODIGE 4 Actions concertées dans les Cancers COloRectaux et Digestifs", | |||
"EDS" : "European Dexamethasone Study", | |||
"SUP-ICU" : "Stress Ulcer Prophylaxis in the Intensive Care Unit", | |||
"ROCKET AF" : "Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation", | |||
"ECASS III" : "European Cooperative Acute Stroke Study III", | |||
"NLST" : "National Lung Screening Trial", | |||
"SALT-ED" : "Saline Against Lactated Ringer's or Plasma-Lyte in the Emergency Department", | |||
"COLCOT" : "Colchicine Cardiovascular Outcomes Trial", | |||
"ISAR-TRIPLE" : "Triple therapy in Patients who Require Oral Anticoagulation After Drug-Eluting Stent Implantation", | |||
"RAMPART" : "Rapid Anticonvulsant Medication Prior to Arrival Trial", | |||
"ADRENAL" : "Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock", | |||
"MASS" : "Multicentre Aneurysm Screening Study", | |||
"IMPROVE-IT" : "IMProved Reduction of Outcomes: Vytorin Efficacy International Trial", | |||
"POP-UP" : "Pantoprazole or Placebo for Stress Ulcer Prophylaxis", | |||
"BRIDGE" : "Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for Elective Invasive Procedure or Surgery", | |||
"PESIT" : "Pulmonary Embolism in Syncope Italian Trial", | |||
"CURE" : "Clopidogrel in Unstable Angina to Prevent Recurrent Events", | |||
"FOCUS" : "Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair", | |||
"CASTLE-AF" : "Catheter Ablation versus Standard Conventional Therapy in Patients with Left Ventricular Dysfunction and Atrial Fibrillation", | |||
"ORBITA" : "Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina", | |||
"ATN" : "Acute Renal Failure Trial Network Study", | |||
"TORCH" : "Towards a Revolution in COPD Health", | |||
"ANNEXA-4" : "Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of Factor Xa Inhibitors", | |||
"TONE" : "Trial of Nonpharmacologic Interventions in the Elderly", | |||
"STOPAH" : "Steroids or Pentoxifylline for Alcoholic Hepatitis", | |||
"REMATCH" : "Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure", | |||
"BICAR-ICU" : "Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill: A Multiple Center Randomized Clinical Trial", | |||
"AAPAC" : "Appendicitis Acuta", | |||
"MIDA" : "Mitral Regurgitation International Database", | |||
"VALIANT" : "Valsartan in Acute Myocardial Infarction Trial", | |||
"UKPDS 34" : "UK Prospective Diabetes Study 34", | |||
"BRIM-3" : "BRAF Inhibitor in Melanoma 3", | |||
"PARTNER B" : "Placement of Aortic Transcatheter Valves, Cohort B", | |||
"CYTO-PV" : "Cytoreductive Therapy in Polycythemia Vera", | |||
"AMPLIFY-EXT" : "Apixaban after the Initial Management of Pulmonary Embolism and Deep Vein Thrombosis with First-Line Therapy-Extended Treatment", | |||
"FLAME COPD" : "Effect of Indacaterol Glycopyronium Vs. Fluticasone Salmeterol on COPD Exacerbations", | |||
"CONSENSUS" : "Cooperative North Scandinavian Enalapril Survival Study", | |||
"STICH" : "Surgical Treatment for Ischemic Heart Failure", | |||
"HOPE-3" : "Heart Outcomes Prevention Evaluation-3", | |||
"ROSE" : "Reevaluation of Systemic Early Neuromuscular Blockade", | |||
"ACT" : "Acetylcysteine for Contrast-Induced Nephropathy Trial", | |||
"ASTRAL" : "Angioplasty and Stenting for Renal Artery Lesions", | |||
"DIG" : "Digitalis Investigation Group", | |||
"FLAME" : "Fluoxetine for Motor Recovery after Acute Ischaemic Stroke", | |||
"RABBIT 2" : "Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes", | |||
"METEOR" : "Meniscal Tear in Osteoarthritis Research", | |||
"CORONA" : "Controlled Rosuvastatin Multinational Trial in Heart Failure", | |||
"AF-CHF" : "Atrial Fibrillation and Congestive Heart Failure", | |||
"NOTT" : "Nocturnal Oxygen Therapy Trial", | |||
"WARFASA" : "Warfarin and Aspirin", | |||
"IDEAL" : "Initiating Dialysis Early and Late", | |||
"SADHAT" : "Sertraline Antidepressant Heart Attack Randomized Trial", | |||
"CATIE-AD" : "Clinical Antipsychotic Trials of Intervention Effectiveness–Alzheimer's Disease", | |||
"MOPETT" : "Moderate Pulmonary Embolism Treated with Thrombolysis", | |||
"NICE-SUGAR" : "Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation", | |||
"ACTIVE A" : "Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events", | |||
"NEAT-HFpEF" : "Nitrate’s Effect on Activity Tolerance in Heart Failure with Preserved Ejection Fraction", | |||
"ELITE-Symphony" : "Efficacy Limiting Toxicity Elimination-Symphony", | |||
"IST" : "International Stroke Trial", | |||
"ATTRACT" : "Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis", | |||
"FOURIER" : "Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk", | |||
"DODS" : "D-dimer Optimal Duration Study", | |||
"ACCOMPLISH" : "Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension", | |||
"HPTN 052" : "HIV Prevention Trials Network 052 Study", | |||
"SURTAVI" : "Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement", | |||
"EMPHASIS-HF" : "Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure", | |||
"POISE" : "PeriOperative ISchemic Evaluation", | |||
"UPLIFT" : "Understanding Potential Long-Term Impacts on Function with Tiotropium", | |||
"CSG Captopril Trial" : "Collaborative Study Group Captopril Trial", | |||
"ODYSSEY LONG TERM" : "Long-term Safety and Tolerability of Alirocumab in High Cardiovascular Risk Patients with Hypercholesterolemia Not\nAdequately Controlled with Their Lipid Modifying Therapy", | |||
"SHOCK" : "SHould we emergently revascularize Occluded Coronaries for Cardiogenic shocK" | |||
} | |||
} | } |